lol, yep they certainly capitalised at an opportune time, now we get to see the opportunity arise from it all.
I wouldn't worry about not knowing about it last year, with the focus groups (specialists who will recommend the Brevagen test) identifying a $150m a year market with women who have test negative to the Myriad Genetics test and the potential 1 million women ($500m market) who have a positive mammogram, we could quite possibly see significant value added just for the US potential alone.
- Forums
- ASX - By Stock
- GTG
- report
report, page-3
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GTG (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.3¢ |
Change
-0.010(15.9%) |
Mkt cap ! $7.007M |
Open | High | Low | Value | Volume |
6.2¢ | 6.2¢ | 5.3¢ | $40.36K | 724.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 5.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 15000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 0.052 |
5 | 249214 | 0.051 |
5 | 162379 | 0.050 |
1 | 20408 | 0.049 |
1 | 40000 | 0.047 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 15000 | 1 |
0.054 | 45000 | 1 |
0.057 | 59470 | 2 |
0.058 | 65555 | 2 |
0.059 | 73500 | 1 |
Last trade - 11.23am 15/07/2024 (20 minute delay) ? |
Featured News
GTG (ASX) Chart |